Navigation Links
EpiCept Corporation to Present New NP-1 Data at American Pain,Society Meeting

of operating losses since our inception; competition; litigation; ; risks associated with our ability to have our common stock readmitted to trading on The Nasdaq Global Market; risks associated with prior material weaknesses in our internal controls; and risks associated with our ability to protect our intellectual property. These factors and other material risks are more fully discussed in EpiCept's periodic reports, including its reports on Forms 8-K, 10-Q and 10-K and other filings with the U.S. Securities and Exchange Commission. You are urged to carefully review and consider the disclosures found in EpiCept's filings which are available at www.sec.gov or at www.epicept.com. You are cautioned not to place undue reliance on any forward-looking statements, any of which could turn out to be wrong due to inaccurate assumptions, unknown risks or uncertainties or other risk factors

CONTACT: Robert W. Cook of EpiCept Corporation, +1-914-606-3572,, or media, Greg Kelley of Feinstein Kean Healthcare,+1-617- 577-8110, , for EpiCept Corporation, orinvestors, Kim Sutton Golodetz, +1-212-838-3777, , orBruce Voss, +1- 310-691-7100, , both of Lippert/Heilshorn &Associates, both for EpiCept Corporation rcook@epicept.com gregory.kelley@fkhealth.com kgolodetz@lhai.comor bvoss@lhai.com

Web site: http://www.epicept.com/

Ticker Symbol: (NASDAQ-NMS:EPCT)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR
2. Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
3. Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron
4. NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis
5. Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results for AT-1001 for the Treatment of Celiac Disease
6. The Past, Present and Future of HLA Typing
7. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
8. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
Post Your Comments:
(Date:12/15/2009)... what something looks like up close and personal? ASPEX ... Electron Microscope (PSEM), kicked off its "Send Us Your ... be scanned by one of their PSEMs. ... to 5mm and an imaging resolution of 25nm, capable ... ASPEX will not only scan your sample, but will ...
(Date:12/15/2009)... -- Cumberland Pharmaceuticals Inc. ( CPIX) ... results for a patient preference study evaluating Kristalose ... laxative packaged as a crystalline powder, compared to ... the only prescription-strength laxative available in pre-measured powder ... a recent diagnosis of chronic constipation were administered ...
(Date:12/15/2009)... Dec. 15 Fenwal Inc., a global ... separation, safety and availability, announced today that the ... approval to market InterSol ® platelet additive ... solution is a specialized product used in combination ... vital blood component used to prevent or treat ...
Breaking Medicine Technology:ASPEX Kicks Off Free 'Send Us Your Sample' Microscopy Campaign 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 3Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets 2Center for Autism and Related Disorders Study Finds Hyperbaric Oxygen Therapy Ineffective Treatment for Children with Autism 61046 1Center for Autism and Related Disorders Study Finds Hyperbaric Oxygen Therapy Ineffective Treatment for Children with Autism 61046 2Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States 6120 1Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States 6120 2Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States 6120 3Trinity Health Selects Seven Elsevier Clinical Decision Support Solutions for its Multiple Facilities In Seven States 6120 4iSirona Selects New Chairman of the Board 14773 1iSirona Selects New Chairman of the Board 14773 2
(Date:12/16/2009)... proud to announce being presented with the Weatherhead 100 Upstart Award ... growing companies in Northeast Ohio and is a testament to hard ... , ... (PRWEB) December 16, 2009 -- Request A ... 100 Upstart Award on December 3, 2009. The Weatherhead 100 ...
(Date:12/16/2009)... to offer free nationwide confidential legal consultations for users of ... as: Birth Defects, Attempted Suicide, Suicide and Addiction Issues. Individuals ... 1-800-856-6405 or go to the firm’s website at http://www.ennislaw.com ... , ... (PRWEB) December 16, 2009 -- ...
(Date:12/15/2009)... researchers have successfully developed a new electrophoretic method ... the blood. The technique, using SARCOSYL-PAGE, has ... alter the performance characteristics of SDS-PAGE for detecting ... by a grant from the World Anti-Doping Agency ... Drug Testing and Analysis published by Wiley-Blackwell. ...
(Date:12/15/2009)... NAPA, Calif., Dec. 15 Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences ... healthy aging, today announced that shareholders had approved all three resolutions that the Company had ... were as follows: , , Description of ... Votes ... For ...
(Date:12/15/2009)... Lupus Foundation of America and the Saint Thomas, Lupus ... Julian Lennon, son of the legendary John Lennon, and ... "LUCY," to raise funds for research on the disease ... of the proceeds from downloading "LUCY" at iTunes will ... and the Saint Thomas, Lupus Trust in Great Britain. ...
Breaking Medicine News(10 mins):Health News:Request A Test Receives Weatherhead 100 Upstart Award 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 3Health News:Researchers discover novel method for detecting MIRCERA 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3Health News:Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research 2
... at Cornell University in Ithaca and Weill Cornell Medical ... of 23 protein biomarkers// in cerebrospinal fluid that acts ... to identify patients living with Alzheimer’s disease. ... of the journal Annals of Neurology. ,Right ...
... AIDS Control Programme (NACP) of India, has come up with ... transmission of HIV/AIDS" //is expected to cost Rs 342.81-crores. ... scheme. ,The fund will also be spent for ... and to provide HIV/AIDS care including antiretroviral therapy to those ...
... facial, dry fruit facial is the new entrant to skin ... dryness of the skin or other beauty related problems, dry ... for skin aliments. ,"This is a new technique and ... Dry fruit facial has benefited several of my clients. It ...
... to utilize original stem cells with the help// of an ... University's Robotics Institute and stem cell researchers from the University ... to organize the growth of stem cells into tissues. , ... team, spent time on mouse stem cells, which were taken ...
... fat in the diet with obesity, diabetes and cardiac ... such as asthma. ,News Limited newspapers reported that ... between fat consumed in a diet and immunity. ... the formation of asthma and other inflammatory diseases whose ...
... An alert has been issued by the Canadian Food Inspection Agency ... of fresh spinach, as they fear that it may be contaminated ... 284-gram packages and bears UPC 0 33383 65201 6 and Dec. ... off the shelves from the shops but the agency fears some ...
Other Medicine News:Health News:Protein ‘Fingerprint’ in Spinal Fluid Could Spot Alzheimer’s Dise 2Health News:Protein ‘Fingerprint’ in Spinal Fluid Could Spot Alzheimer’s Dise 3
... Used for temporary internal ... to the bladder. Supplied sterile ... one-time use. CAUTION: Periodic evaluation ... Sof-Flex stents must not remain ...
Used for stenting the urethra after hypospadias or epispadias repair and to provide post-operative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
... Used for catheter or instrument introduction. ... to be peeled away and removed. ... or instrument to be introduced should ... through the sheath. Supplied sterile in ...
Used to gain percutaneous access into the renal pelvis to treat stone disease. The dual lumen catheter and the Peel-Away® introducer are sized for use in pediatric patients. Supplied sterile in p...
Medicine Products: